Results
Twenty-four infants were enrolled and randomized to receive the 3 study therapies ordered as shown in Figure 2. Two subjects were withdrawn from the trial prior to completing all 3 drugs owing to the development of an exclusion criterion after the trial started (development of airway leak >10% and need for HFV). All available study data were used in the analyses. Demographic information for all enrolled subjects is shown in Table 1.